Drug class in one race
OX40 (agonist) drugs for Non-Small Cell Lung Cancer
3 tracked OX40 (agonist) drugs in the Non-Small Cell Lung Cancer race. The class explanation lives on the OX40 (agonist) page; the full indication pipeline across every mechanism is on the Non-Small Cell Lung Cancer page.
1 Phase 21 Phase 1/21 Phase 1